ND0611
- Generic Name
- ND0611
Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611
- First Posted Date
- 2010-04-13
- Last Posted Date
- 2010-10-05
- Lead Sponsor
- NeuroDerm Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT01103011
- Locations
- 🇮🇱
Hadassah Medical Center, Jerusalem, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath